Snapshot
The global mRNA Vaccines & Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of mRNA Vaccines & Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- Standardization Of Cancer Treatment MRNA Vaccine
- Individualized Cancer Treatment MRNA Vaccine
- Infectious Disease Treatment MRNA Vaccine
- Infection Prevention MRNA Vaccine
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
- Argos Therapeutics
- AstraZeneca
- Bayer
- BioNTech
- Boehringer Ingelheim
- CRISPR Therapeutics
- CureVac
- eTheRNA immunotherapies
- Ethris
- GlaxoSmithKline Vaccines
- In-Cell-Art
- Intellia Therapeutics
- Janssen
- Kernal Biologics
- MaxCyte
- Moderna Therapeutics
- Novartis
- PhaseRx
- Precision NanoSystems
- RaNa Therapeutics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
- Hospital
- Clinic
- Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
- Asia-Pacific (China, India, Japan, Southeast Asia etc.)
- South America (Brazil, Argentina etc.)
- Middle East & Africa (Saudi Arabia, South Africa etc.)
Global mRNA Vaccines & Therapeutics Market Analysis 2016-2020 and Forecast 2021-2026
Table of Contents
1 Industry Overview
1.1 mRNA Vaccines & Therapeutics Industry
Figure mRNA Vaccines & Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of mRNA Vaccines & Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of mRNA Vaccines & Therapeutics
1.2.2 Downstream
Table Application Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 mRNA Vaccines & Therapeutics Market by Type
3.1 By Type
3.1.1 Standardization Of Cancer Treatment MRNA Vaccine
Table Major Company List of Standardization Of Cancer Treatment MRNA Vaccine
3.1.2 Individualized Cancer Treatment MRNA Vaccine
Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
3.1.3 Infectious Disease Treatment MRNA Vaccine
Table Major Company List of Infectious Disease Treatment MRNA Vaccine
3.1.4 Infection Prevention MRNA Vaccine
Table Major Company List of Infection Prevention MRNA Vaccine
3.2 Market Size
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in USD Million
Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in Volume
Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Argos Therapeutics (Company Profile, Sales Data etc.)
4.1.1 Argos Therapeutics Profile
Table Argos Therapeutics Overview List
4.1.2 Argos Therapeutics Products & Services
4.1.3 Argos Therapeutics Business Operation Conditions
Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.2.2 AstraZeneca Products & Services
4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 BioNTech (Company Profile, Sales Data etc.)
4.4.1 BioNTech Profile
Table BioNTech Overview List
4.4.2 BioNTech Products & Services
4.4.3 BioNTech Business Operation Conditions
Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.5.2 Boehringer Ingelheim Products & Services
4.5.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 CRISPR Therapeutics (Company Profile, Sales Data etc.)
4.6.1 CRISPR Therapeutics Profile
Table CRISPR Therapeutics Overview List
4.6.2 CRISPR Therapeutics Products & Services
4.6.3 CRISPR Therapeutics Business Operation Conditions
Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 CureVac (Company Profile, Sales Data etc.)
4.7.1 CureVac Profile
Table CureVac Overview List
4.7.2 CureVac Products & Services
4.7.3 CureVac Business Operation Conditions
Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 eTheRNA immunotherapies (Company Profile, Sales Data etc.)
4.8.1 eTheRNA immunotherapies Profile
Table eTheRNA immunotherapies Overview List
4.8.2 eTheRNA immunotherapies Products & Services
4.8.3 eTheRNA immunotherapies Business Operation Conditions
Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Ethris (Company Profile, Sales Data etc.)
4.9.1 Ethris Profile
Table Ethris Overview List
4.9.2 Ethris Products & Services
4.9.3 Ethris Business Operation Conditions
Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 GlaxoSmithKline Vaccines (Company Profile, Sales Data etc.)
4.10.1 GlaxoSmithKline Vaccines Profile
Table GlaxoSmithKline Vaccines Overview List
4.10.2 GlaxoSmithKline Vaccines Products & Services
4.10.3 GlaxoSmithKline Vaccines Business Operation Conditions
Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 In-Cell-Art (Company Profile, Sales Data etc.)
4.11.1 In-Cell-Art Profile
Table In-Cell-Art Overview List
4.11.2 In-Cell-Art Products & Services
4.11.3 In-Cell-Art Business Operation Conditions
Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Intellia Therapeutics (Company Profile, Sales Data etc.)
4.12.1 Intellia Therapeutics Profile
Table Intellia Therapeutics Overview List
4.12.2 Intellia Therapeutics Products & Services
4.12.3 Intellia Therapeutics Business Operation Conditions
Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
4.13 Janssen (Company Profile, Sales Data etc.)
4.13.1 Janssen Profile
Table Janssen Overview List
4.13.2 Janssen Products & Services
4.13.3 Janssen Business Operation Conditions
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Kernal Biologics (Company Profile, Sales Data etc.)
4.14.1 Kernal Biologics Profile
Table Kernal Biologics Overview List
4.14.2 Kernal Biologics Products & Services
4.14.3 Kernal Biologics Business Operation Conditions
Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
4.15 MaxCyte (Company Profile, Sales Data etc.)
4.15.1 MaxCyte Profile
Table MaxCyte Overview List
4.15.2 MaxCyte Products & Services
4.15.3 MaxCyte Business Operation Conditions
Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
4.16 Moderna Therapeutics (Company Profile, Sales Data etc.)
4.16.1 Moderna Therapeutics Profile
Table Moderna Therapeutics Overview List
4.16.2 Moderna Therapeutics Products & Services
4.16.3 Moderna Therapeutics Business Operation Conditions
Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
4.17 Novartis (Company Profile, Sales Data etc.)
4.17.1 Novartis Profile
Table Novartis Overview List
4.17.2 Novartis Products & Services
4.17.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
4.18 PhaseRx (Company Profile, Sales Data etc.)
4.18.1 PhaseRx Profile
Table PhaseRx Overview List
4.18.2 PhaseRx Products & Services
4.18.3 PhaseRx Business Operation Conditions
Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
4.19 Precision NanoSystems (Company Profile, Sales Data etc.)
4.19.1 Precision NanoSystems Profile
Table Precision NanoSystems Overview List
4.19.2 Precision NanoSystems Products & Services
4.19.3 Precision NanoSystems Business Operation Conditions
Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)
4.20 RaNa Therapeutics (Company Profile, Sales Data etc.)
4.20.1 RaNa Therapeutics Profile
Table RaNa Therapeutics Overview List
4.20.2 RaNa Therapeutics Products & Services
4.20.3 RaNa Therapeutics Business Operation Conditions
Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global mRNA Vaccines & Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Volume 2016-2020, by Company, in Volume
Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2020
Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2020
Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2020
Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2020
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in Others
Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in USD Million
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in Volume
Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of mRNA Vaccines & Therapeutics
2. Table Application Segment of mRNA Vaccines & Therapeutics
3. Table Global mRNA Vaccines & Therapeutics Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
5. Table Major Company List of Infectious Disease Treatment MRNA Vaccine
6. Table Major Company List of Infection Prevention MRNA Vaccine
7. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in USD Million
8. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in Volume
9. Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in USD Million
10. Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in Volume
11. Table Argos Therapeutics Overview List
12. Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table AstraZeneca Overview List
14. Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Bayer Overview List
16. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table BioNTech Overview List
18. Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Boehringer Ingelheim Overview List
20. Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table CRISPR Therapeutics Overview List
22. Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table CureVac Overview List
24. Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table eTheRNA immunotherapies Overview List
26. Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Ethris Overview List
28. Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table GlaxoSmithKline Vaccines Overview List
30. Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table In-Cell-Art Overview List
32. Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Intellia Therapeutics Overview List
34. Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
35. Table Janssen Overview List
36. Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
37. Table Kernal Biologics Overview List
38. Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
39. Table MaxCyte Overview List
40. Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
41. Table Moderna Therapeutics Overview List
42. Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
43. Table Novartis Overview List
44. Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
45. Table PhaseRx Overview List
46. Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
47. Table Precision NanoSystems Overview List
48. Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)
49. Table RaNa Therapeutics Overview List
50. Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
51. Table Global mRNA Vaccines & Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
52. Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
53. Table Global mRNA Vaccines & Therapeutics Sales Volume 2016-2020, by Company, in Volume
54. Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
55. Table Regional Demand Comparison List
56. Table Major Application in Different Regions
57. Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
58. Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in Volume
59. Table mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in Volume
60. Table mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in Volume
61. Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in USD Million
62. Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in Volume
63. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in USD Million
64. Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in USD Million
65. Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in Volume
66. Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in Volume
67. Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
68. Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
69. Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
70. Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
71. Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
72. Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
73. Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
74. Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
75. Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
76. Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
77. Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in USD Million
78. Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in Volume
79. Table Price Factors List
List of Figure
1. Figure mRNA Vaccines & Therapeutics Industry Chain Structure
2. Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in USD Million
3. Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in Volume
4. Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2020, by Company, in Volume
6. Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2020
7. Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2020
8. Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2020
9. Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2020
10. Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2020
11. Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in USD Million
12. Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in Volume
13. Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in USD Million
14. Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in Volume
15. Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in USD Million
16. Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in Volume
17. Figure mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in USD Million
18. Figure mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in USD Million
19. Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
20. Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
21. Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
22. Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
25. Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
26. Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
